Anzeige
Mehr »
Lynx Broker
Login
Montag, 19.08.2019 Börsentäglich über 12.000 News von 605 internationalen Medien

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
Zur alten Webversion

Aktuelle News von BioPharma-Reporter

  • 24 h
  • letzte 200 News
ZeitAktuelle Nachrichten
DoLeo to market AstraZeneca's psoriasis treatment outside the EU
DoMerck collaborates to examine Keytruda in combination with investigational drug
DoTraceability is key in the growing global cold chain market
MiEMA tells companies to declare peptone use in biologics fermentation
MiIn riposte to AbbVie, Revance talks up prospects of biosimilar Botox
MiCourt sides with Amgen in Enbrel biosimilar patent case
DiBayer acquires cell therapies developer BlueRock
DiExpanded approval of Dupixent scratches an unmet itch
DiRegenerative medicines global revenues down by 40%, but 'poised for growth'
08.08.BMS leases biologic development space in New Jersey to PTC
08.08.Pfizer ramps up bioprocessing capacity for DMD gene therapy trial
08.08.Vida generates $600m, triples assets to expand life sciences platform
07.08.BLA for Novartis' $2.1m gene therapy potentially contains accurate data
07.08.BLA for Novartis' $2.1m gene therapy potentially contains inaccurate data
07.08.Fujifilm aims to become a 'total healthcare company', acquires Biogen facility
07.08.EQT VIII Fund invests in Aldevron, supports capacity expansion
07.08.Singapore biomedical manufacturing up by 9.6% in 2019
05.08.What it takes to lead a cell and gene therapy company
02.08.Genomic data on cancer treatment released to public
01.08.Lonza, Vineti team up to address risks in the 'vein-to-vein' supply chain
01.08.Lonza to continue narsoplimab manufacture for Omeros
01.08.WHO indicates preferred HIV treatment
31.07.Gilead's Yescarta edges ahead of Kymriah in CAR-T race
30.07.Sales of Keytruda leads Merck to strong Q2
29.07.July roundup sees flurry of partnership deals